logologo
QuantliQuantli

Oruka Therapeutics Inc

ORKA

NASDAQ

Biotechnology

$111.04

USD

+2.92 (+2.70%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $7.11B

Volume 1.0M

Price Target

$120.00$151.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $151.00 and a min estimate of $120.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$133.67

+$21.3 vs prior

Implied Upside

+20.4%

+19.2% vs prior

Analyst Covering

3

-5 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

27%

Many ratings are older - consensus may be less current

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$3.67 Gap

Median $130.00 vs avg $133.67 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Mitchell S. Kapoor

HC Wainwright & Co.

Buy

Reiterated

1 week ago

Plus
Plus
Plus

Julian Harrison

BTIG

Buy

Reiterated

4 weeks ago

Plus
Plus
Plus

Michael Yee

Jefferies

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

TWST

Twist Bioscience Corp

$118.57

-5.4%

RYTM

Rhythm Pharmaceuticals Inc

$115.48

-0.5%

IBRX

Immunitybio Inc

$7.57

-1.1%

MIRM

Mirum Pharmaceuticals Inc

$100.64

+1.9%

CGON

CG Oncology Inc

$75.03

+0.4%

COGT

Cogent Biosciences Inc

$37.93

+1.7%

TGTX

TG Therapeutics Inc

$48.74

+1.7%

DNTH

Dianthus Therapeutics Inc

$115.96

+5.8%